+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 75Years
All Genders
ID07185373

Randomized Trial of Orelabrutinib with Teniposide, Rituximab, and Methotrexate for New Primary Central Nervous System Lymphoma

Led by Huashan Hospital · Updated on 2026-08-19

215

Participants Needed

15

Research Sites

43 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a randomized controlled trial to compare three different induction treatment regimens for adults aged 18 to 75 years who have newly diagnosed primary central nervous system lymphoma PCNSL. The study aims to evaluate how well each treatment leads to complete or unconfirmed complete responses during the initial therapy phase. Participants will be assigned to treatment groups based on age and performance status to ensure balanced comparison. The trial includes three treatment arms given in 21-day cycles Arm A receives teniposide, orelabrutinib, rituximab, methotrexate MTX, and dexamethasone Arm B receives orelabrutinib, rituximab, MTX, and dexamethasone and Arm C receives rituximab, MTX, and dexamethasone. After completing induction therapy, those who achieve a complete or unconfirmed complete response may proceed to consolidation therapy, which may include chemotherapy, stem cell transplantation, reduced-dose brain radiotherapy, or other treatments chosen by the investigator. Participants will undergo regular assessments during and after treatment cycles, with evaluations at the end of six cycles to measure response rates. Researchers will monitor survival outcomes over two years following treatment start. Study involvement includes clinical examinations, laboratory tests, and imaging as needed to assess treatment effects and safety. Participants are expected to attend scheduled visits throughout the treatment and follow-up periods, which may last several years in total.

CONDITIONS

Brief Title

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Research Team

T

Tong Chen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here